Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Xcytrin evaluated in combination with Rituxan and Zevalin

Nov. 10, 2003

New EGFR inhibitors discovered at Boehringer Ingelheim

Nov. 10, 2003

Good efficacy and safety profile reported for arzoxifene in hormone-sensitive breast cancer

Nov. 10, 2003

Troxacitabine safety and efficacy in CML-BP

Nov. 7, 2003

Oral topoisomerase I inhibitor added to Novartis pipeline

Nov. 7, 2003

Abbott researchers describe new protein kinase inhibitors, their preparation and use

Nov. 7, 2003

New antitumor compounds identified at Welichem

Nov. 7, 2003

Eisai patent covers new hemiasterlin analogues for cancer therapy

Nov. 7, 2003

YM BioSciences cleared to begin pivotal trial of tesmilifene

Nov. 6, 2003

Ark Therapeutics granted patent for EG-009

Nov. 6, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...